Supplementary Table from ARRY-382 in Combination with Pembrolizumab in Patients with Advanced Solid Tumors: Results from a Phase 1b/2 Study

Authors :: Jonathan W. Goldman
Yuanyuan Zhang
S. Michael Rothenberg
Allison Harney
Adele Golden
Patrice Lee
John Sarantopoulos
Justin F. Gainor
Karl Lewis
Paul R. Kunk
Justin Call
Ammar Sukari
Arkadiusz Z. Dudek
Melissa Johnson
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Supplementary Table from ARRY-382 in Combination with Pembrolizumab in Patients with Advanced Solid Tumors: Results from a Phase 1b/2 Study

Tools